These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15618286)

  • 1. Novel association of Vav2 and Nek3 modulates signaling through the human prolactin receptor.
    Miller SL; DeMaria JE; Freier DO; Riegel AM; Clevenger CV
    Mol Endocrinol; 2005 Apr; 19(4):939-49. PubMed ID: 15618286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells.
    Miller SL; Antico G; Raghunath PN; Tomaszewski JE; Clevenger CV
    Oncogene; 2007 Jul; 26(32):4668-78. PubMed ID: 17297458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration.
    Harrington KM; Clevenger CV
    J Biol Chem; 2016 Oct; 291(41):21388-21406. PubMed ID: 27489110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma.
    McHale K; Tomaszewski JE; Puthiyaveettil R; Livolsi VA; Clevenger CV
    Mod Pathol; 2008 May; 21(5):565-71. PubMed ID: 18246042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.
    Liu BP; Burridge K
    Mol Cell Biol; 2000 Oct; 20(19):7160-9. PubMed ID: 10982832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EHD2 mediates trafficking from the plasma membrane by modulating Rac1 activity.
    Benjamin S; Weidberg H; Rapaport D; Pekar O; Nudelman M; Segal D; Hirschberg K; Katzav S; Ehrlich M; Horowitz M
    Biochem J; 2011 Nov; 439(3):433-42. PubMed ID: 21756249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer.
    Cho CY; Lee KT; Chen WC; Wang CY; Chang YS; Huang HL; Hsu HP; Yen MC; Lai MZ; Lai MD
    Oncotarget; 2016 Mar; 7(12):14586-604. PubMed ID: 26910843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vav family proteins couple to diverse cell surface receptors.
    Moores SL; Selfors LM; Fredericks J; Breit T; Fujikawa K; Alt FW; Brugge JS; Swat W
    Mol Cell Biol; 2000 Sep; 20(17):6364-73. PubMed ID: 10938113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel and functional interaction between cyclophilin A and prolactin receptor.
    Syed F; Rycyzyn MA; Westgate L; Clevenger CV
    Endocrine; 2003; 20(1-2):83-90. PubMed ID: 12668872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.
    Heo J; Thapar R; Campbell SL
    Biochemistry; 2005 May; 44(17):6573-85. PubMed ID: 15850391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vav2 is an activator of Cdc42, Rac1, and RhoA.
    Abe K; Rossman KL; Liu B; Ritola KD; Chiang D; Campbell SL; Burridge K; Der CJ
    J Biol Chem; 2000 Apr; 275(14):10141-9. PubMed ID: 10744696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and association of the Tec tyrosine kinase with the human prolactin receptor: mapping of a Tec/Vav1-receptor binding site.
    Kline JB; Moore DJ; Clevenger CV
    Mol Endocrinol; 2001 May; 15(5):832-41. PubMed ID: 11328862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth.
    Bourguignon LY; Zhu H; Zhou B; Diedrich F; Singleton PA; Hung MC
    J Biol Chem; 2001 Dec; 276(52):48679-92. PubMed ID: 11606575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vav1, but not Vav2, contributes to platelet aggregation by CRP and thrombin, but neither is required for regulation of phospholipase C.
    Pearce AC; Wilde JI; Doody GM; Best D; Inoue O; Vigorito E; Tybulewicz VL; Turner M; Watson SP
    Blood; 2002 Nov; 100(10):3561-9. PubMed ID: 12411320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis.
    Hunter SG; Zhuang G; Brantley-Sieders D; Swat W; Cowan CW; Chen J
    Mol Cell Biol; 2006 Jul; 26(13):4830-42. PubMed ID: 16782872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells.
    Citterio C; Menacho-Márquez M; García-Escudero R; Larive RM; Barreiro O; Sánchez-Madrid F; Paramio JM; Bustelo XR
    Sci Signal; 2012 Oct; 5(244):ra71. PubMed ID: 23033540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
    Ferrag F; Chiarenza A; Goffin V; Kelly PA
    Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2.
    Garrett TA; Van Buul JD; Burridge K
    Exp Cell Res; 2007 Sep; 313(15):3285-97. PubMed ID: 17686471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.
    Gao J; Hughes JP; Auperin B; Buteau H; Edery M; Zhuang H; Wojchowski DM; Horseman ND
    Mol Endocrinol; 1996 Jul; 10(7):847-56. PubMed ID: 8813725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.